Intellia Therapeutics to Present at September Investor Healthcare Conferences

CAMBRIDGE, Mass., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, announced that CEO and Founder Nessan Bermingham, Ph.D., will present at key September investor healthcare conferences, including the 2016 Wells Fargo Healthcare Conference, the Morgan Stanley Global Healthcare Conference and the Leerink Rare Disease & IO Roundtable Series.

Details of the upcoming presentations are as follows:

Wednesday, September 7th

2016 Wells Fargo Healthcare Conference

Location: The Westin Waterfront, Boston

Presentation Time: 3:30-4:00 PM ET

Tuesday, September 13th

2016 Morgan Stanley Global Healthcare Conference

Location: Grand Hyatt New York, New York

Presentation Time: 5:15-5:40 PM ET

Wednesday, September 28th

Leerink Rare Disease & IO Roundtable Series, 2016

Location: Lotte New York Palace, New York

Presentation Time: 2:05-2:30 PM ET

Individuals may access the presentations for each conference via live webcast on the Intellia website at www.intelliatx.com under "Events & Presentations" in the "Investor Relations" section. A replay of the webcast will be available on this site for 90 days following the live event.

About Intellia Therapeutics

Jennifer Mound Smoter

Chief External Affairs & Communications Officer

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!

Already have an account? Log in here.